CYTEK BIOSCIENCES, INC. Basic Shares Outstanding (Weighted Average)
CYTEK BIOSCIENCES, INC. (CTKB) reported Basic Shares Outstanding (Weighted Average) of 129.46 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 129.46M shares, a 1.99% increase year-over-year.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 128.70M shares, a 0.28% increase year-over-year.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 128.17M shares, a 0.71% decline year-over-year.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 127.55M shares, a 2.64% decline year-over-year.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 127.75M shares, a 2.19% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 130.61M shares, a 3.45% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 135.28M shares, a 0.57% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 134.51M shares, a 75.28% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 129.46M shares 10-Q · filed 2026-08-05 | 129.08M shares 10-Q · filed 2026-08-05 | 128.78M shares derived: average of 3 quarters · filed 2026-08-05 | 128.47M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 128.70M shares 10-Q · filed 2026-05-07 | 128.44M shares derived: average of 2 quarters · filed 2026-05-07 | 128.14M shares derived: average of 3 quarters · filed 2026-05-07 | 127.84M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 128.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 127.86M shares derived: average of 2 quarters · filed 2026-02-26 | 127.55M shares derived: average of 3 quarters · filed 2026-08-05 | 127.75M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 127.55M shares 10-Q · filed 2025-11-05 | 127.24M shares derived: average of 2 quarters · filed 2026-08-05 | 127.60M shares 10-Q · filed 2025-11-05 | 127.98M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 126.93M shares 10-Q · filed 2026-08-05 | 127.63M shares 10-Q · filed 2026-08-05 | 128.12M shares derived: average of 3 quarters · filed 2026-08-05 | 128.84M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 128.34M shares 10-Q · filed 2026-05-07 | 128.71M shares derived: average of 2 quarters · filed 2026-05-07 | 129.47M shares derived: average of 3 quarters · filed 2026-05-07 | 129.97M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 129.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 130.04M shares derived: average of 2 quarters · filed 2026-02-26 | 130.51M shares derived: average of 3 quarters · filed 2026-02-26 | 130.61M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 131.00M shares 10-Q · filed 2025-11-05 | 131.22M shares derived: average of 2 quarters · filed 2025-11-05 | 131.12M shares 10-Q · filed 2025-11-05 | 131.73M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 131.44M shares 10-Q · filed 2025-08-06 | 131.18M shares 10-Q · filed 2025-08-06 | 131.97M shares derived: average of 3 quarters · filed 2026-02-26 | 133.02M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 130.92M shares 10-Q · filed 2025-05-08 | 132.23M shares derived: average of 2 quarters · filed 2026-02-26 | 133.55M shares derived: average of 3 quarters · filed 2026-02-26 | 134.14M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 133.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 134.86M shares derived: average of 2 quarters · filed 2026-02-26 | 135.21M shares derived: average of 3 quarters · filed 2026-02-26 | 135.28M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 136.17M shares 10-Q · filed 2024-11-07 | 136.05M shares derived: average of 2 quarters · filed 2024-11-07 | 135.86M shares 10-Q · filed 2024-11-07 | 135.65M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 135.92M shares 10-Q · filed 2024-08-06 | 135.71M shares 10-Q · filed 2024-08-06 | 135.48M shares derived: average of 3 quarters · filed 2025-02-28 | 135.28M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 135.49M shares 10-Q · filed 2024-05-08 | 135.25M shares derived: average of 2 quarters · filed 2025-02-28 | 135.07M shares derived: average of 3 quarters · filed 2025-02-28 | 134.91M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 135.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 134.86M shares derived: average of 2 quarters · filed 2025-02-28 | 134.71M shares derived: average of 3 quarters · filed 2025-02-28 | 134.51M shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 134.71M shares 10-Q · filed 2023-11-14 | 134.56M shares derived: average of 2 quarters · filed 2023-11-14 | 134.34M shares 10-Q · filed 2023-11-14 | 134.35M shares derived: average of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | 134.40M shares 10-Q · filed 2023-08-08 | 134.15M shares 10-Q · filed 2023-08-08 | 134.22M shares derived: average of 3 quarters · filed 2024-03-13 | 127.75M shares derived: average of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | 133.90M shares 10-Q · filed 2023-05-09 | 134.13M shares derived: average of 2 quarters · filed 2024-03-13 | 125.53M shares derived: average of 3 quarters · filed 2024-03-13 | 102.12M shares derived: average of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | 134.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 121.34M shares derived: average of 2 quarters · filed 2024-03-13 | 91.52M shares derived: average of 3 quarters · filed 2024-03-13 | 76.74M shares 10-K · filed 2024-03-13 |
| 2021-09-30 | 108.32M shares 10-Q · filed 2022-11-09 | 70.10M shares derived: average of 2 quarters · filed 2022-11-09 | 57.53M shares 10-Q · filed 2022-11-09 | 50.65M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 31.88M shares 10-Q · filed 2022-08-10 | 31.72M shares 10-Q · filed 2022-08-10 | 31.43M shares derived: average of 3 quarters · filed 2023-03-01 | 30.75M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 31.56M shares 10-Q · filed 2022-05-12 | 31.21M shares derived: average of 2 quarters · filed 2023-03-01 | 30.37M shares derived: average of 3 quarters · filed 2023-03-01 | 29.90M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 30.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 29.78M shares derived: average of 2 quarters · filed 2023-03-01 | 29.35M shares derived: average of 3 quarters · filed 2023-03-01 | 29.13M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 28.70M shares 10-Q · filed 2021-11-12 | 28.60M shares derived: average of 2 quarters · filed 2021-11-12 | 28.55M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 28.50M shares 10-Q · filed 2021-09-03 | 28.48M shares 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |